{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,5,14]],"date-time":"2025-05-14T04:22:31Z","timestamp":1747196551766,"version":"3.40.5"},"reference-count":45,"publisher":"Public Library of Science (PLoS)","issue":"10","license":[{"start":{"date-parts":[[2024,10,8]],"date-time":"2024-10-08T00:00:00Z","timestamp":1728345600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"abstract":"<jats:sec id=\"sec001\">\n<jats:title>Background<\/jats:title>\n<jats:p>Chronic hepatitis B virus (HBV) infection is still a major public health problem. In response to the World Health Organization (WHO), Tanzania implemented immunization and treatment to achieve the eradication of HBV infection by 2030. To achieve this goal, frequent updates of demographic data, antiviral therapy eligibility, and uptake are essential. We therefore evaluated demographic data, antiviral therapy eligibility, and uptake among chronically HBV-infected patients attending at Bugando Medical Centre (BMC), Tanzania.<\/jats:p>\n<\/jats:sec>\n<jats:sec id=\"sec002\">\n<jats:title>Methods<\/jats:title>\n<jats:p>A cross-sectional study enrolled 196 chronic HBV patients from April 23, 2023, to October 10, 2023, at BMC, where 100 and 96 patients were retrospectively and prospectively enrolled, respectively. Study\u2019s ethical clearance and permission were observed by the Catholic University of Health and Allied Sciences\/Bugando Medical Centre research ethics and review committee and the Bugando Medical Centre management respectively. For all patients, socio-demographic data and whole blood samples were obtained. Full blood picture, alanine and aspartate amino transferases, and HBV viral load parameters were determined. Aspartate-Platelet Ratio Index (APRI) and Fibrosis Four (FIB-4) scores were calculated according to their respective formulas. Therapy eligibility and uptake were evaluated according to the 2015 WHO HBV prevention, treatment, and care guidelines. The data were summarized and analysed using STATA version 15.<\/jats:p>\n<\/jats:sec>\n<jats:sec id=\"sec003\">\n<jats:title>Results<\/jats:title>\n<jats:p>The median age for all patients was 39 [IQR: 32\u201347.5] years. Nearly all study patients, 99% (194\/196), were older than 20 years old, with significant male dominance (73.5% [144\/196] versus 26.5% [52\/196]; p&lt;0.0001). Anti-HBV antiviral therapy eligibility was 22.4%, while uptake was 6.8% (3\/4), which was significantly lower than the WHO expectation of 80% (p &lt;0.0001).<\/jats:p>\n<\/jats:sec>\n<jats:sec id=\"sec004\">\n<jats:title>Conclusion<\/jats:title>\n<jats:p>Almost all chronically HBV-infected patients attending at BMC were older than 20 years old and were significantly dominated by males. Antiviral therapy uptake was remarkably lower than expected by the WHO towards combating HBV infection by 2030.<\/jats:p>\n<\/jats:sec>","DOI":"10.1371\/journal.pone.0309314","type":"journal-article","created":{"date-parts":[[2024,10,8]],"date-time":"2024-10-08T17:26:36Z","timestamp":1728408396000},"page":"e0309314","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":0,"title":["Hepatitis B infection: Evaluation of demographics and treatment of chronic hepatitis B infection in Northern-western Tanzania"],"prefix":"10.1371","volume":"19","author":[{"ORCID":"https:\/\/orcid.org\/0009-0009-7432-8723","authenticated-orcid":true,"given":"Mathias","family":"Mlewa","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Helmut A.","family":"Nyawale","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3659-0615","authenticated-orcid":true,"given":"Shimba","family":"Henerico","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ivon","family":"Mangowi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Aminiel Robert","family":"Shangali","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anselmo Mathias","family":"Manisha","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Felix","family":"Kisanga","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Benson R.","family":"Kidenya","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8712-7976","authenticated-orcid":true,"given":"Hyasinta","family":"Jaka","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Semvua B.","family":"Kilonzo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mariam M.","family":"Mirambo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stephen E.","family":"Mshana","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"340","published-online":{"date-parts":[[2024,10,8]]},"reference":[{"key":"pone.0309314.ref001","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s13690-021-00686-1","article-title":"Prevalence and predictors of hepatitis B virus (HBV) infection in east Africa: evidence from a systematic review and meta-analysis of epidemiological studies published from 2005 to 2020","volume":"79","author":"HM Kafeero","year":"2021","journal-title":"Archives of Public Health"},{"key":"pone.0309314.ref002","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12879-020-05096-2","article-title":"Prevalence of chronic HBV infection in pregnant woman attending antenatal care in a tertiary hospital in Mwanza, Tanzania: a cross-sectional study","volume":"20","author":"K Geffert","year":"2020","journal-title":"BMC infectious diseases"},{"key":"pone.0309314.ref003","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12879-015-1129-z","article-title":"Prevalence of hepatitis B virus infection among health care workers in a tertiary hospital in Tanzania","volume":"15","author":"A Mueller","year":"2015","journal-title":"BMC infectious diseases"},{"issue":"3","key":"pone.0309314.ref004","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1056\/NEJMoa013215","article-title":"Hepatitis B e antigen and the risk of hepatocellular carcinoma","volume":"347","author":"H-I Yang","year":"2002","journal-title":"New England Journal of Medicine"},{"issue":"2","key":"pone.0309314.ref005","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1002\/hep.23348","article-title":"Age\u2010specific prognosis following spontaneous hepatitis B e antigen seroconversion in chronic hepatitis B","volume":"51","author":"YC Chen","year":"2010","journal-title":"Hepatology"},{"issue":"1","key":"pone.0309314.ref006","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1186\/s12916-023-03082-4","article-title":"Five-year results of a treatment program for chronic hepatitis B in Ethiopia","volume":"21","author":"H Desalegn","year":"2023","journal-title":"BMC medicine"},{"issue":"8804","key":"pone.0309314.ref007","doi-asserted-by":"crossref","first-page":"1287","DOI":"10.1016\/0140-6736(92)91605-8","article-title":"WHO: World Health Assembly","volume":"339","author":"A McGregor","year":"1992","journal-title":"The Lancet"},{"journal-title":"NATIONAL STRATEGIC PLAN FOR THE CONTROL OF VIRAL HEPATITIS","year":"2023","author":"TANZANIA MINISTRY OF HEALTH CD G","key":"pone.0309314.ref008"},{"key":"pone.0309314.ref009","doi-asserted-by":"crossref","first-page":"1152193","DOI":"10.3389\/fpubh.2023.1152193","article-title":"Low uptake of hepatitis B vaccination among healthcare workers in primary health facilities in Mwanza region, North-Western Tanzania","volume":"11","author":"B Ndunguru","year":"2023","journal-title":"Frontiers in Public Health"},{"journal-title":"Guidelines for the preventioncare and treatment of persons with chronic hepatitis B infection","year":"2015","author":"ORGANIZATION WH","key":"pone.0309314.ref010"},{"issue":"6","key":"pone.0309314.ref011","doi-asserted-by":"crossref","first-page":"2142","DOI":"10.1002\/hep.26578","article-title":"AASLD clinical practice guidelines: a critical review of scientific evidence and evolving recommendations","volume":"58","author":"C Koh","year":"2013","journal-title":"Hepatology"},{"issue":"2","key":"pone.0309314.ref012","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1016\/j.jhep.2017.03.021","article-title":"EASL 2017 Clinical Practice Guidelines on the management of hepatitis B virus infection","volume":"67","author":"K Agarwal","year":"2017","journal-title":"Journal of hepatology"},{"journal-title":"2021 WHO Guidelines for the preventiondiagnosis, care and treatment for people with chronic hepatitis B infection","year":"2024","author":"Organization WH","key":"pone.0309314.ref013"},{"issue":"1","key":"pone.0309314.ref014","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1002\/hep.28280","article-title":"Antiviral therapy for chronic hepatitis B viral infection in adults: a systematic review and meta\u2010analysis","volume":"63","author":"AS Lok","year":"2016","journal-title":"Hepatology"},{"issue":"6","key":"pone.0309314.ref015","doi-asserted-by":"crossref","first-page":"1129","DOI":"10.1016\/j.jhep.2018.01.031","article-title":"Eight-year survival in chronic hepatitis B patients under long-term entecavir or tenofovir therapy is similar to the general population","volume":"68","author":"GV Papatheodoridis","year":"2018","journal-title":"Journal of hepatology"},{"issue":"1","key":"pone.0309314.ref016","doi-asserted-by":"crossref","first-page":"610","DOI":"10.1186\/s12879-021-06226-0","article-title":"Hepatitis B virus (HBV) viral load, liver and renal function in adults treated with tenofovir disoproxil fumarate (TDF) vs. untreated: a retrospective longitudinal UK cohort study","volume":"21","author":"T Wang","year":"2021","journal-title":"BMC infectious diseases"},{"issue":"3\u20134","key":"pone.0309314.ref017","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1159\/000360949","article-title":"Reduction of infectivity in chronic hepatitis B virus carriers among healthcare providers and pregnant women by antiviral therapy","volume":"57","author":"WH Gerlich","year":"2014","journal-title":"Intervirology"},{"issue":"10","key":"pone.0309314.ref018","doi-asserted-by":"crossref","first-page":"299","DOI":"10.4236\/ojgas.2023.1310027","article-title":"Antiviral Therapy Eligibility and Low Treatment Coverage among Hepatitis B Virus Infected Patients in Tanzania","volume":"13","author":"SB Kilonzo","year":"2023","journal-title":"Open Journal of Gastroenterology"},{"journal-title":"Elimination of viral hepatitis by 2030","year":"2016","author":"ORGANIZATION WH","key":"pone.0309314.ref019"},{"key":"pone.0309314.ref020","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/j.jcv.2018.01.012","article-title":"Performance of the cobas Hepatitis B virus (HBV) test using the cobas 4800 system and comparison of HBV DNA quantification ability between the COBAS AmpliPrep\/COBAS TaqMan HBV test version 2.0 and cobas HBV test.","volume":"101","author":"K-H Shin","year":"2018","journal-title":"Journal of Clinical Virology"},{"issue":"4","key":"pone.0309314.ref021","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1016\/S1665-2681(19)31836-8","article-title":"AST to platelet ratio index (APRI) for the noninvasive evaluation of liver fibrosis","volume":"7","author":"A Loaeza-del-Castillo","year":"2008","journal-title":"Annals of hepatology"},{"key":"pone.0309314.ref022","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/1471-230X-11-44","article-title":"A comparison of four fibrosis indexes in chronic HCV: development of new fibrosis-cirrhosis index (FCI)","volume":"11","author":"W Ahmad","year":"2011","journal-title":"BMC gastroenterology"},{"key":"pone.0309314.ref023","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1016\/j.bjid.2019.10.001","article-title":"The effectiveness of the national hepatitis B vaccination program 25 years after its introduction in Iran: a historical cohort study.","volume":"23","author":"M Moghadami","year":"2020","journal-title":"Brazilian Journal of Infectious Diseases"},{"issue":"5","key":"pone.0309314.ref024","doi-asserted-by":"crossref","first-page":"1140","DOI":"10.3390\/microorganisms11051140","article-title":"Vertical Transmission of Hepatitis B Virus\u2014An Update.","volume":"11","author":"D di Filippo Villa","year":"2023","journal-title":"Microorganisms"},{"issue":"5","key":"pone.0309314.ref025","doi-asserted-by":"crossref","first-page":"1048","DOI":"10.1099\/jgv.0.000776","article-title":"Molecular epidemiology of hepatitis B virus infection in Tanzania","volume":"98","author":"JC Forbi","year":"2017","journal-title":"Journal of General Virology"},{"key":"pone.0309314.ref026","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1111\/j.1440-1746.2010.06541.x","article-title":"The clinical implications of hepatitis B virus genotype: Recent advances","volume":"26","author":"CL Lin","year":"2011","journal-title":"Journal of gastroenterology and hepatology"},{"issue":"1","key":"pone.0309314.ref027","doi-asserted-by":"crossref","first-page":"e0227041","DOI":"10.1371\/journal.pone.0227041","article-title":"Eligibility for hepatitis B antiviral therapy among adults in the general population in Zambia","volume":"15","author":"MJ Vinikoor","year":"2020","journal-title":"PLoS One"},{"key":"pone.0309314.ref028","doi-asserted-by":"crossref","first-page":"754711","DOI":"10.3389\/fviro.2022.754711","article-title":"TREAT-B algorithm for treatment eligibility among chronically infected Hepatitis B virus persons in a low and a high endemic region: a potential strategy towards virus elimination by 2030","volume":"2","author":"HM Kafeero","year":"2022","journal-title":"Frontiers in virology"},{"key":"pone.0309314.ref029","doi-asserted-by":"crossref","first-page":"995857","DOI":"10.3389\/fmed.2022.995857","article-title":"Assessment and validation of the TREAT-B score to assess the treatment eligibility of patients with chronic hepatitis B virus infection","volume":"9","author":"K Thanapirom","year":"2022","journal-title":"Frontiers in Medicine"},{"issue":"4","key":"pone.0309314.ref030","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1016\/j.jhep.2018.06.002","article-title":"Predicting treatment eligibility for hepatitis B in low income regions: Can treatment scores without HBV DNA testing serve the purpose?","volume":"69","author":"BJ McMahon","year":"2018","journal-title":"Journal of Hepatology"},{"issue":"3","key":"pone.0309314.ref031","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1002\/ueg2.12376","article-title":"Eligibility for antiviral therapy and treatment uptake in chronic hepatitis B patients referred to a European tertiary care center","volume":"11","author":"M Jachs","year":"2023","journal-title":"United European Gastroenterology Journal"},{"key":"pone.0309314.ref032","first-page":"ofac707","volume-title":"In: Open Forum Infectious Diseases: 2023","author":"BB Phinius","year":"2023"},{"issue":"2","key":"pone.0309314.ref033","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/S2055-6640(20)30484-2","article-title":"Analysis of minimum target prices for production of entecavir to treat hepatitis B in high-and low-income countries","volume":"1","author":"A Hill","year":"2015","journal-title":"Journal of virus eradication"},{"issue":"1","key":"pone.0309314.ref034","doi-asserted-by":"crossref","first-page":"S76","DOI":"10.1016\/j.jhep.2015.01.018","article-title":"Strategies to control hepatitis B: Public policy, epidemiology, vaccine and drugs","volume":"62","author":"S Locarnini","year":"2015","journal-title":"Journal of hepatology"},{"key":"pone.0309314.ref035","doi-asserted-by":"crossref","first-page":"842944","DOI":"10.3389\/fphar.2022.842944","article-title":"Impact of National Volume-Based Procurement on the procurement volumes and spending for antiviral medications of hepatitis B virus","volume":"13","author":"J Yuan","year":"2022","journal-title":"Frontiers in Pharmacology"},{"issue":"1","key":"pone.0309314.ref036","first-page":"335","article-title":"Tanzania middle income country status and implications for future economic growth strategies","volume":"21","author":"FM Turuka","year":"2022","journal-title":"Tanzania Journal of Agricultural Sciences"},{"issue":"1","key":"pone.0309314.ref037","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1016\/j.jcv.2012.05.011","article-title":"Virological and epidemiological features of hepatitis delta infection among blood donors in Nouakchott, Mauritania","volume":"55","author":"W Mansour","year":"2012","journal-title":"Journal of Clinical Virology"},{"issue":"2","key":"pone.0309314.ref038","doi-asserted-by":"crossref","first-page":"36","DOI":"10.5501\/wjv.v4.i2.36","article-title":"Molecular interactions between hepatitis B virus and delta virus","volume":"4","author":"E Shirvani-Dastgerdi","year":"2015","journal-title":"World Journal of Virology"},{"issue":"3","key":"pone.0309314.ref039","doi-asserted-by":"crossref","first-page":"e0152043","DOI":"10.1371\/journal.pone.0152043","article-title":"Hepatitis B infection, viral load and resistance in HIV-infected patients in Mozambique and Zambia","volume":"11","author":"G Wandeler","year":"2016","journal-title":"PloS one"},{"key":"pone.0309314.ref040","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1007\/s11904-010-0066-0","article-title":"Revisiting immune exhaustion during HIV infection","volume":"8","author":"A Khaitan","year":"2011","journal-title":"Current HIV\/AIDS Reports"},{"issue":"12","key":"pone.0309314.ref041","doi-asserted-by":"crossref","first-page":"100593","DOI":"10.1016\/j.jhepr.2022.100593","article-title":"Clinical and virological features of chronic hepatitis B in the French national surveillance program, 2008\u20132012: A cross-sectional study","volume":"4","author":"S Chevaliez","year":"2022","journal-title":"JHEP Reports"},{"issue":"3","key":"pone.0309314.ref042","doi-asserted-by":"crossref","first-page":"678","DOI":"10.1053\/j.gastro.2005.11.016","article-title":"Predicting cirrhosis risk based on the level of circulating hepatitis B viral load","volume":"130","author":"UH Iloeje","year":"2006","journal-title":"Gastroenterology"},{"issue":"1","key":"pone.0309314.ref043","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1001\/jama.295.1.65","article-title":"Risk of hepatocellular carcinoma across a biological gradient of serum hepatitis B virus DNA level","volume":"295","author":"C-J Chen","year":"2006","journal-title":"Jama"},{"issue":"5","key":"pone.0309314.ref044","doi-asserted-by":"crossref","first-page":"788","DOI":"10.1016\/j.bj.2021.09.001","article-title":"Different impacts of common risk factors associated with thrombocytopenia in patients with hepatitis B virus and hepatitis C virus infection","volume":"45","author":"C-E Huang","year":"2022","journal-title":"biomedical journal"},{"journal-title":"The prevalence of thrombocytopenia in patients with chronic hepatitis B and C","year":"2006","author":"B Behnava","key":"pone.0309314.ref045"}],"container-title":["PLOS ONE"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0309314","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,10,8]],"date-time":"2024-10-08T17:26:48Z","timestamp":1728408408000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0309314"}},"subtitle":[],"editor":[{"given":"Jason T.","family":"Blackard","sequence":"first","affiliation":[],"role":[{"role":"editor","vocabulary":"crossref"}]}],"short-title":[],"issued":{"date-parts":[[2024,10,8]]},"references-count":45,"journal-issue":{"issue":"10","published-online":{"date-parts":[[2024,10,8]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0309314","relation":{},"ISSN":["1932-6203"],"issn-type":[{"type":"electronic","value":"1932-6203"}],"subject":[],"published":{"date-parts":[[2024,10,8]]}}}